Definitive Healthcare Corp.
DHHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframePart of the healthcare sector, Definitive Healthcare Corp. (DH) is listed under Health Information Services. At a $115.3M market cap, Definitive Healthcare Corp. ranks as a micro-cap company within healthcare. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Market Cap
$115.3M
Beta
1.40
P/E (TTM)
—
P/E (Fwd)
5.79
EPS (TTM)
$-1.61
EPS (Fwd)
$0.19
ROE
-78.4%
ROA
-1.9%
Cash
$183.8M
Total Debt
$167.1M
Free CF
$50.4M
52W Change
-63.6%
Annual Financials
Cash vs Debt
Where DH stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, DH finished 22.22% above its 150-day moving average ($0.90) and 3.51% below its 200-day moving average ($1.14). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is DH overbought or oversold?
At the October 20, 2026 close, DH's RSI(14) was 80.6, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $183.8M in cash and $167.1M in debt, DH maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $50.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -78.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $222.7M (2022) to $241.5M (2025).
Investors considering Definitive Healthcare Corp. should weigh the typical risks associated with DH's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing DH.